Clinical characteristics | Number (n) | % |
---|---|---|
Total number | 71 | 100 |
Age (years) | ||
Median | 59 | |
Range | 29 - 75 | |
Gender | ||
Male | 48 | 68 |
Female | 23 | 32 |
Disease stage | ||
IIIA | 66 | 93 |
IIIB | 5 | 7 |
Tumor classification | ||
T1 | 7 | 10 |
T2 | 43 | 60 |
T3 | 16 | 23 |
T4 | 5 | 7 |
Lymph node status | ||
N2 | 71 | 100 |
Tumor location | ||
Right upper lobe | 28 | 39 |
Right middle lobe/central | 5 | 7 |
Right lower lobe | 9 | 13 |
Left upper lobe | 16 | 23 |
Left lower lobe | 13 | 18 |
Tumor histology | ||
Squamous cell | 25 | 35 |
Adenocarcinoma | 41 | 58 |
Large cell | 3 | 4 |
Other | 2 | 3 |
Surgery type | ||
Lobectomy | 44 | 62 |
Bi-lobectomy | 7 | 10 |
Pneumonectomy | 20 | 28 |
Resection status | ||
R0 | 53 | 75 |
R1 | 18 | 25 |
Resected lymph nodes | ||
Median | 33 | |
Range | 10 – 60 | |
Chemotherapy | ||
Induction | 23 | 32 |
Adjuvant | 48 | 68 |
RT dose (Gy) | ||
Median | 50 | |
Range | 40 - 60 |